Loading…
Impaired neutrophil chemotaxis in Crohn's disease relates to reduced production of chemokines and can be augmented by granulocyte‐colony stimulating factor
Summary Background Defective neutrophil recruitment has been described as a primary pathogenic abnormality in Crohn’s disease. Cantharidin‐induced blisters provide a novel investigative tool to assess cellular influx and inflammatory mediator production during acute inflammation and allows the effec...
Saved in:
Published in: | Alimentary pharmacology & therapeutics 2006-08, Vol.24 (4), p.651-660 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c5336-752fb55a4985997db3338a2a33413a6b62b3a8286166043e4b35d6eaebf053e43 |
---|---|
cites | cdi_FETCH-LOGICAL-c5336-752fb55a4985997db3338a2a33413a6b62b3a8286166043e4b35d6eaebf053e43 |
container_end_page | 660 |
container_issue | 4 |
container_start_page | 651 |
container_title | Alimentary pharmacology & therapeutics |
container_volume | 24 |
creator | HARBORD, M. W. N. MARKS, D. J. B. FORBES, A. BLOOM, S. L. DAY, R. M. SEGAL, A. W. |
description | Summary
Background
Defective neutrophil recruitment has been described as a primary pathogenic abnormality in Crohn’s disease. Cantharidin‐induced blisters provide a novel investigative tool to assess cellular influx and inflammatory mediator production during acute inflammation and allows the effects of therapy on these parameters to be measured.
Aims
To determine whether reduced neutrophil tissue penetration in Crohn's disease relates to impaired production of inflammatory mediators, and whether it can be reversed by granulocyte‐colony stimulating factor (G‐CSF).
Methods
Neutrophil and monocyte/macrophage populations and inflammatory mediators were measured in cantharidin blisters at 24 h. Neutrophil chemotaxis was assessed in vitro using blister fluid as the chemoattractant. The effect of s.c. G‐CSF on blister phenotype was determined.
Results
Significantly fewer neutrophils migrated into blisters in Crohn's patients. The production of neutrophil chemokines, but not other inflammatory mediators, was reduced. This significantly correlated with reduced chemotaxis in vitro. Differences were unrelated to caspase‐recruitment domain 15 genotype. G‐CSF significantly increased blister neutrophil concentrations in control subjects and Crohn's patients.
Conclusions
Reduced neutrophil migration during acute inflammation in Crohn's disease is associated with impaired production of appropriate chemoattractants. G‐CSF therapy increases neutrophil tissue migration, which may partially account for its observed therapeutic effect. |
doi_str_mv | 10.1111/j.1365-2036.2006.03016.x |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2648502</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68743715</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5336-752fb55a4985997db3338a2a33413a6b62b3a8286166043e4b35d6eaebf053e43</originalsourceid><addsrcrecordid>eNqNkk2O1DAQhS0EYpqGKyBvgFWCfxInWYA0ajEw0kiwGNZWxXG63SR2sJOhs-MIcwEux0lw6NYMrMAbl-XvPVXpFUKYkpTG83qfUi7yhBEuUkaISAknVKSHB2h19_EQrQgTVcJKys_QkxD2JJIFYY_RGRUVKcqqXKEfl_0AxusGWz2N3g0702G1070b4WACNhZvvNvZVwE3JmgIGnvdwagDHl0sm0lF7eBdLEbjLHbtUf7F2MiAbbACi2uNYdr22o6Rrme89WCnzql51D-_3yrXOTvjMJp-it7GbnELanT-KXrUQhf0s9O9Rp8v3l1vPiRXH99fbs6vEpVzLpIiZ22d55BVZV5VRVNzzktgwHlGOYhasJpDyUpBhSAZ11nN80Zo0HVL8vjka_T26DtMda8bFfv00MnBmx78LB0Y-fePNTu5dTeSiazMCYsGL08G3n2ddBhlb4LSXQdWuylIURYZL2j-T5BWWcYXeI3KI6i8C8Hr9q4bSuSyBHIvl6zlkrVclkD-XgJ5iNLnf05zLzylHoEXJwCCgq6NYSgT7rmiqihny1Rvjtw30-n5vxuQ55-ul4r_AvKm0n0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19443874</pqid></control><display><type>article</type><title>Impaired neutrophil chemotaxis in Crohn's disease relates to reduced production of chemokines and can be augmented by granulocyte‐colony stimulating factor</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>HARBORD, M. W. N. ; MARKS, D. J. B. ; FORBES, A. ; BLOOM, S. L. ; DAY, R. M. ; SEGAL, A. W.</creator><creatorcontrib>HARBORD, M. W. N. ; MARKS, D. J. B. ; FORBES, A. ; BLOOM, S. L. ; DAY, R. M. ; SEGAL, A. W.</creatorcontrib><description>Summary
Background
Defective neutrophil recruitment has been described as a primary pathogenic abnormality in Crohn’s disease. Cantharidin‐induced blisters provide a novel investigative tool to assess cellular influx and inflammatory mediator production during acute inflammation and allows the effects of therapy on these parameters to be measured.
Aims
To determine whether reduced neutrophil tissue penetration in Crohn's disease relates to impaired production of inflammatory mediators, and whether it can be reversed by granulocyte‐colony stimulating factor (G‐CSF).
Methods
Neutrophil and monocyte/macrophage populations and inflammatory mediators were measured in cantharidin blisters at 24 h. Neutrophil chemotaxis was assessed in vitro using blister fluid as the chemoattractant. The effect of s.c. G‐CSF on blister phenotype was determined.
Results
Significantly fewer neutrophils migrated into blisters in Crohn's patients. The production of neutrophil chemokines, but not other inflammatory mediators, was reduced. This significantly correlated with reduced chemotaxis in vitro. Differences were unrelated to caspase‐recruitment domain 15 genotype. G‐CSF significantly increased blister neutrophil concentrations in control subjects and Crohn's patients.
Conclusions
Reduced neutrophil migration during acute inflammation in Crohn's disease is associated with impaired production of appropriate chemoattractants. G‐CSF therapy increases neutrophil tissue migration, which may partially account for its observed therapeutic effect.</description><identifier>ISSN: 0269-2813</identifier><identifier>EISSN: 1365-2036</identifier><identifier>DOI: 10.1111/j.1365-2036.2006.03016.x</identifier><identifier>PMID: 16907898</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Adult ; Aged ; Biological and medical sciences ; Chemokines - metabolism ; Chemotaxis, Leukocyte - physiology ; Crohn Disease - drug therapy ; Crohn Disease - immunology ; Crohn Disease - metabolism ; Digestive system ; Female ; Gastroenterology. Liver. Pancreas. Abdomen ; Granulocyte Colony-Stimulating Factor - therapeutic use ; Humans ; Male ; Medical sciences ; Middle Aged ; Neutrophils - physiology ; Other diseases. Semiology ; Pharmacology. Drug treatments ; Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</subject><ispartof>Alimentary pharmacology & therapeutics, 2006-08, Vol.24 (4), p.651-660</ispartof><rights>2006 INIST-CNRS</rights><rights>2006 Blackwell Publishing Ltd 2006</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5336-752fb55a4985997db3338a2a33413a6b62b3a8286166043e4b35d6eaebf053e43</citedby><cites>FETCH-LOGICAL-c5336-752fb55a4985997db3338a2a33413a6b62b3a8286166043e4b35d6eaebf053e43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17991322$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16907898$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>HARBORD, M. W. N.</creatorcontrib><creatorcontrib>MARKS, D. J. B.</creatorcontrib><creatorcontrib>FORBES, A.</creatorcontrib><creatorcontrib>BLOOM, S. L.</creatorcontrib><creatorcontrib>DAY, R. M.</creatorcontrib><creatorcontrib>SEGAL, A. W.</creatorcontrib><title>Impaired neutrophil chemotaxis in Crohn's disease relates to reduced production of chemokines and can be augmented by granulocyte‐colony stimulating factor</title><title>Alimentary pharmacology & therapeutics</title><addtitle>Aliment Pharmacol Ther</addtitle><description>Summary
Background
Defective neutrophil recruitment has been described as a primary pathogenic abnormality in Crohn’s disease. Cantharidin‐induced blisters provide a novel investigative tool to assess cellular influx and inflammatory mediator production during acute inflammation and allows the effects of therapy on these parameters to be measured.
Aims
To determine whether reduced neutrophil tissue penetration in Crohn's disease relates to impaired production of inflammatory mediators, and whether it can be reversed by granulocyte‐colony stimulating factor (G‐CSF).
Methods
Neutrophil and monocyte/macrophage populations and inflammatory mediators were measured in cantharidin blisters at 24 h. Neutrophil chemotaxis was assessed in vitro using blister fluid as the chemoattractant. The effect of s.c. G‐CSF on blister phenotype was determined.
Results
Significantly fewer neutrophils migrated into blisters in Crohn's patients. The production of neutrophil chemokines, but not other inflammatory mediators, was reduced. This significantly correlated with reduced chemotaxis in vitro. Differences were unrelated to caspase‐recruitment domain 15 genotype. G‐CSF significantly increased blister neutrophil concentrations in control subjects and Crohn's patients.
Conclusions
Reduced neutrophil migration during acute inflammation in Crohn's disease is associated with impaired production of appropriate chemoattractants. G‐CSF therapy increases neutrophil tissue migration, which may partially account for its observed therapeutic effect.</description><subject>Adult</subject><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Chemokines - metabolism</subject><subject>Chemotaxis, Leukocyte - physiology</subject><subject>Crohn Disease - drug therapy</subject><subject>Crohn Disease - immunology</subject><subject>Crohn Disease - metabolism</subject><subject>Digestive system</subject><subject>Female</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Granulocyte Colony-Stimulating Factor - therapeutic use</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Neutrophils - physiology</subject><subject>Other diseases. Semiology</subject><subject>Pharmacology. Drug treatments</subject><subject>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</subject><issn>0269-2813</issn><issn>1365-2036</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNqNkk2O1DAQhS0EYpqGKyBvgFWCfxInWYA0ajEw0kiwGNZWxXG63SR2sJOhs-MIcwEux0lw6NYMrMAbl-XvPVXpFUKYkpTG83qfUi7yhBEuUkaISAknVKSHB2h19_EQrQgTVcJKys_QkxD2JJIFYY_RGRUVKcqqXKEfl_0AxusGWz2N3g0702G1070b4WACNhZvvNvZVwE3JmgIGnvdwagDHl0sm0lF7eBdLEbjLHbtUf7F2MiAbbACi2uNYdr22o6Rrme89WCnzql51D-_3yrXOTvjMJp-it7GbnELanT-KXrUQhf0s9O9Rp8v3l1vPiRXH99fbs6vEpVzLpIiZ22d55BVZV5VRVNzzktgwHlGOYhasJpDyUpBhSAZ11nN80Zo0HVL8vjka_T26DtMda8bFfv00MnBmx78LB0Y-fePNTu5dTeSiazMCYsGL08G3n2ddBhlb4LSXQdWuylIURYZL2j-T5BWWcYXeI3KI6i8C8Hr9q4bSuSyBHIvl6zlkrVclkD-XgJ5iNLnf05zLzylHoEXJwCCgq6NYSgT7rmiqihny1Rvjtw30-n5vxuQ55-ul4r_AvKm0n0</recordid><startdate>20060815</startdate><enddate>20060815</enddate><creator>HARBORD, M. W. N.</creator><creator>MARKS, D. J. B.</creator><creator>FORBES, A.</creator><creator>BLOOM, S. L.</creator><creator>DAY, R. M.</creator><creator>SEGAL, A. W.</creator><general>Blackwell Publishing Ltd</general><general>Blackwell</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QR</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20060815</creationdate><title>Impaired neutrophil chemotaxis in Crohn's disease relates to reduced production of chemokines and can be augmented by granulocyte‐colony stimulating factor</title><author>HARBORD, M. W. N. ; MARKS, D. J. B. ; FORBES, A. ; BLOOM, S. L. ; DAY, R. M. ; SEGAL, A. W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5336-752fb55a4985997db3338a2a33413a6b62b3a8286166043e4b35d6eaebf053e43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Chemokines - metabolism</topic><topic>Chemotaxis, Leukocyte - physiology</topic><topic>Crohn Disease - drug therapy</topic><topic>Crohn Disease - immunology</topic><topic>Crohn Disease - metabolism</topic><topic>Digestive system</topic><topic>Female</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Granulocyte Colony-Stimulating Factor - therapeutic use</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Neutrophils - physiology</topic><topic>Other diseases. Semiology</topic><topic>Pharmacology. Drug treatments</topic><topic>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>HARBORD, M. W. N.</creatorcontrib><creatorcontrib>MARKS, D. J. B.</creatorcontrib><creatorcontrib>FORBES, A.</creatorcontrib><creatorcontrib>BLOOM, S. L.</creatorcontrib><creatorcontrib>DAY, R. M.</creatorcontrib><creatorcontrib>SEGAL, A. W.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Chemoreception Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Alimentary pharmacology & therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>HARBORD, M. W. N.</au><au>MARKS, D. J. B.</au><au>FORBES, A.</au><au>BLOOM, S. L.</au><au>DAY, R. M.</au><au>SEGAL, A. W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impaired neutrophil chemotaxis in Crohn's disease relates to reduced production of chemokines and can be augmented by granulocyte‐colony stimulating factor</atitle><jtitle>Alimentary pharmacology & therapeutics</jtitle><addtitle>Aliment Pharmacol Ther</addtitle><date>2006-08-15</date><risdate>2006</risdate><volume>24</volume><issue>4</issue><spage>651</spage><epage>660</epage><pages>651-660</pages><issn>0269-2813</issn><eissn>1365-2036</eissn><abstract>Summary
Background
Defective neutrophil recruitment has been described as a primary pathogenic abnormality in Crohn’s disease. Cantharidin‐induced blisters provide a novel investigative tool to assess cellular influx and inflammatory mediator production during acute inflammation and allows the effects of therapy on these parameters to be measured.
Aims
To determine whether reduced neutrophil tissue penetration in Crohn's disease relates to impaired production of inflammatory mediators, and whether it can be reversed by granulocyte‐colony stimulating factor (G‐CSF).
Methods
Neutrophil and monocyte/macrophage populations and inflammatory mediators were measured in cantharidin blisters at 24 h. Neutrophil chemotaxis was assessed in vitro using blister fluid as the chemoattractant. The effect of s.c. G‐CSF on blister phenotype was determined.
Results
Significantly fewer neutrophils migrated into blisters in Crohn's patients. The production of neutrophil chemokines, but not other inflammatory mediators, was reduced. This significantly correlated with reduced chemotaxis in vitro. Differences were unrelated to caspase‐recruitment domain 15 genotype. G‐CSF significantly increased blister neutrophil concentrations in control subjects and Crohn's patients.
Conclusions
Reduced neutrophil migration during acute inflammation in Crohn's disease is associated with impaired production of appropriate chemoattractants. G‐CSF therapy increases neutrophil tissue migration, which may partially account for its observed therapeutic effect.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>16907898</pmid><doi>10.1111/j.1365-2036.2006.03016.x</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0269-2813 |
ispartof | Alimentary pharmacology & therapeutics, 2006-08, Vol.24 (4), p.651-660 |
issn | 0269-2813 1365-2036 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2648502 |
source | Wiley-Blackwell Read & Publish Collection |
subjects | Adult Aged Biological and medical sciences Chemokines - metabolism Chemotaxis, Leukocyte - physiology Crohn Disease - drug therapy Crohn Disease - immunology Crohn Disease - metabolism Digestive system Female Gastroenterology. Liver. Pancreas. Abdomen Granulocyte Colony-Stimulating Factor - therapeutic use Humans Male Medical sciences Middle Aged Neutrophils - physiology Other diseases. Semiology Pharmacology. Drug treatments Stomach. Duodenum. Small intestine. Colon. Rectum. Anus |
title | Impaired neutrophil chemotaxis in Crohn's disease relates to reduced production of chemokines and can be augmented by granulocyte‐colony stimulating factor |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T14%3A48%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impaired%20neutrophil%20chemotaxis%20in%20Crohn's%20disease%20relates%20to%20reduced%20production%20of%20chemokines%20and%20can%20be%20augmented%20by%20granulocyte%E2%80%90colony%20stimulating%20factor&rft.jtitle=Alimentary%20pharmacology%20&%20therapeutics&rft.au=HARBORD,%20M.%20W.%20N.&rft.date=2006-08-15&rft.volume=24&rft.issue=4&rft.spage=651&rft.epage=660&rft.pages=651-660&rft.issn=0269-2813&rft.eissn=1365-2036&rft_id=info:doi/10.1111/j.1365-2036.2006.03016.x&rft_dat=%3Cproquest_pubme%3E68743715%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5336-752fb55a4985997db3338a2a33413a6b62b3a8286166043e4b35d6eaebf053e43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=19443874&rft_id=info:pmid/16907898&rfr_iscdi=true |